SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Rami Manochakian

Rami Manochakian

Mayo Clinic, Jacksonville

Dr. Rami Manochakian is a thoracic medical oncologist at Mayo Clinic in Jacksonville, Florida, where he serves as Vice Chair for Education and Hematology/Oncology Fellowship Program Director. His clinical and research work focuses on non-small cell and small cell lung cancer, malignant pleural mesothelioma, and thymic tumors, and he contributes expert commentary on emerging therapies such as targeted agents in HER2-mutant NSCLC and tarlatamab in SCLC. A Fellow of ASCO, he holds education and advisory roles with ASCO, the International Association for the Study of Lung Cancer, and the American Lung Association, and is a frequent speaker at major international oncology congresses.

Connect

Rami Manochakian

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates